Clinical efficacy and safety of apatinib combined with EGFR-TKIs in advanced non-small cell lung cancer with EGFR-TKIs resistance

被引：0
|
作者：
Tian, Ruifen [1 ]
Guo, Yi [1 ]
Zhang, Xia [1 ]
Zhang, Xing [1 ]
Guo, Wei [1 ]
Zhu, Haibo [1 ]
Xu, Junjun [1 ]
Shen, Fangfang [1 ]
Song, Xia [1 ]
机构：
[1] Shanxi Prov Tumor Hosp, Taiyuan, Shanxi, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21172
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21172
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical Efficacy and Safety of Apatinib Combined with EGFR - TKIs in Advanced Non-Small Cell Lung Cancer with EGFR - TKIs Resistance
    Song, X.
    Tian, R.
    Guo, Y.
    Zhang, X.
    Guo, W.
    Zhu, H.
    Shen, F.
    Xu, J.
    Zhang, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S590 - S590
  • [2] Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance
    Li, Fang
    Zhu, Tengjiao
    Cao, Baoshan
    Wang, Jiadong
    Liang, Li
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 184 - 192
  • [3] Efficacy and safety of bevacizumab combined with EGFR-TKIs in advanced non-small cell lung cancer: A meta-analysis
    Yang, Yifan
    Wang, Liming
    Li, Xu
    Zhang, Shuai
    Yu, Jiangyong
    Nie, Xin
    Liu, Wenbo
    Wu, Xiaonan
    Zhang, Ping
    Li, Yi
    Li, Ailing
    Ai, Bin
    THORACIC CANCER, 2022, 13 (01) : 31 - 37
  • [4] Safety of EGFR-TKIs for EGFR mutation-positive non-small cell lung cancer
    Zhou, Jia-Ying
    Liu, Si-Yang
    Wu, Yi-Long
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (05) : 589 - 599
  • [5] THE RESISTANCE TO EGFR-TKIS IN LUNG CANCER
    Yamada, T.
    Yano, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 77 - 77
  • [6] Clinical efficacy of EGFR-TKIs in combination with chemotherapy in patients with advanced non-small cell lung cancer harboring EGFR mutations
    Zhang, Minghui
    Liu, Mingyang
    Wang, Yan
    JOURNAL OF THORACIC DISEASE, 2016, 8 (10) : E1293 - E1295
  • [7] The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer
    Zhao, Dan
    Chen, Xuejing
    Qin, Na
    Su, Dan
    Zhou, Lijuan
    Zhang, Quan
    Li, Xi
    Zhang, Xinyong
    Jin, Mulan
    Wang, Jinghui
    SCIENTIFIC REPORTS, 2017, 7
  • [8] The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer
    Dan Zhao
    Xuejing Chen
    Na Qin
    Dan Su
    Lijuan Zhou
    Quan Zhang
    Xi Li
    Xinyong Zhang
    Mulan Jin
    Jinghui Wang
    Scientific Reports, 7
  • [9] Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer
    Shi, Xiaoshun
    Dong, Xiaoying
    Zhai, Jianxue
    Liu, Xiguang
    Lu, Di
    Ni, Zhen
    Wu, Hua
    Cai, Kaican
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Chemotherapy plus EGFR-TKIs versus EGFR-TKIs Alone in Non-small Cell Lung Cancer with EGFR-Activating Mutations: A Meta-analysis
    Han, G.
    Peng, M.
    Weng, Y.
    Zou, J.
    Song, Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E458 - E458
12345